Cargando…
Interaction of Amyloid Inhibitor Proteins with Amyloid Beta Peptides: Insight from Molecular Dynamics Simulations
Knowledge of the detailed mechanism by which proteins such as human αB- crystallin and human lysozyme inhibit amyloid beta (Aβ) peptide aggregation is crucial for designing treatment for Alzheimer's disease. Thus, unconstrained, atomistic molecular dynamics simulations in explicit solvent have...
Autores principales: | Das, Payel, Kang, Seung-gu, Temple, Sally, Belfort, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244084/ https://www.ncbi.nlm.nih.gov/pubmed/25422897 http://dx.doi.org/10.1371/journal.pone.0113041 |
Ejemplares similares
-
Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017) -
Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
por: Aloufi, Bandar, et al.
Publicado: (2022) -
Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico
por: Rosenthal, Joseph, et al.
Publicado: (2016) -
Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2011) -
New Insights in the Amyloid-Beta Interaction with Mitochondria
por: Spuch, Carlos, et al.
Publicado: (2012)